Clorhexil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clorhexil

What is Clorhexil? Defining the Active Ingredient and Class

Property Description
Active ingredient Chlorhexidine Gluconate (CHG)
Form Oral rinse, Topical solution, Gel
Pharmacological class Antiseptic and Germicide
General use Antimicrobial control and hygiene
Origin Synthetic bisbiguanide compound

Clorhexil is a trade name for preparations containing the active ingredient Chlorhexidine Gluconate (CHG), a synthetic bisbiguanide compound that is classified primarily as an Antiseptic and Germicide. This means it is a chemical agent designed to reduce or prevent the growth of microorganisms, serving as a powerful topical antimicrobial and distinguishing it from antibiotics, which work systemically inside the body. Clorhexil formulations, often optimized for oral care, are clinically recognized for their application in mucosal application and are typically manufactured as an aqueous solution.


Common Forms and General Antiseptic Purpose

Chlorhexidine Gluconate is administered via the topical route and is commonly available in several dosage forms, including oral rinse (mouthwash), topical solution, topical spray, and gingival gel. Its function as a broad-spectrum biocide allows it to target a wide range of common germs, including Gram-positive and Gram-negative bacteria and fungi. The primary general purpose of these products is to achieve effective, sustained antimicrobial control on surfaces like the skin or the oral mucosa, thereby serving the goal of reducing the microbial load to maintain hygiene and support preparatory cleanliness. This substance is considered a gold standard for its antimicrobial efficacy in oral applications. This indicates that the compound is highly regarded by dental professionals for its germ-fighting capabilities.


How Does the Bisbiguanide Compound Work?

The fundamental mechanism principle is based on the strong attraction of the bisbiguanide compound to the negatively charged surfaces of microbial cell membranes. When applied, Chlorhexidine Gluconate binds to the cell walls of microbes, physically disrupting their integrity, which results in a definitive bactericidal action (killing the microbes). The compound's structural chemistry also results in substantivity, a unique residual binding property that prolongs the antiseptic action and offers sustained germ reduction beyond the initial application. The efficacy of CHG for its intended uses in various antiseptic solutions is established.

What side effects are possible with Clorhexil?

Possible Side Effects and Safety Information

The safety profile of Chlorhexidine Gluconate (the active ingredient in Clorhexil) is structured around officially documented adverse reactions classified by frequency and affected organ system. Most documented effects are localized and temporary, reflecting the substance's primary use as a topical antiseptic with poor systemic absorption.


Officially Documented Adverse Reactions

Classification Examples of Documented Effects
Very Common Taste disturbance (dysgeusia), coating of the tongue, reversible staining of the teeth and oral restorations.
Common Dry mouth, local hypersensitivity reactions, parotid gland swelling, and discomfort in the mouth.

These effects are typically categorized under Gastrointestinal disorders or Salivary gland disorders in regulatory documents. Taste changes are often noted to occur at the initiation of treatment and may diminish with continued use. Conversely, the risk and severity of staining are documented to increase with the duration of use.


Serious Reactions and Safety Constraints

The most clinically significant safety considerations pertain to the Immune system disorders. Rare but serious adverse reactions, including anaphylaxis (a severe, systemic allergic reaction) and angioedema, are officially documented. This leads to the formal contraindication of the product in any individual with a known history of hypersensitivity to Chlorhexidine Gluconate or any formulation excipient.

Official labeling also includes restrictions, such as the mandate that the product is for external/local application only and must not contact sensitive tissues like the eyes or nervous tissue (meninges). This regulatory structure defines the risks associated with the medicine, focusing on common local effects and the need to avoid use in hypersensitive individuals.

Overdose and Emergency Response

Accidental ingestion of a large volume of Chlorhexidine Gluconate solution may lead to systemic toxicity, resulting in several documented overdose presentations. Symptoms reported primarily affect the Central Nervous System, causing headache, giddiness, blurred vision, slurred speech, and eventual unresponsiveness or coma. Gastrointestinal effects include nausea, vomiting, and abdominal pain. Severe outcomes documented in regulatory literature include Methemoglobinemia and profound hypotension (low blood pressure), classifying the overdose as life-threatening. Special consideration is given to children, where ingestion of alcohol-containing formulations may present with signs of intoxication, and the elderly, where severe outcomes have been reported.

Mandated Emergency Response

Emergency medical attention is required for two distinct scenarios. First, contact 911 or the national Poison Help hotline immediately following any suspected accidental ingestion of a large volume. Second, regulatory agencies mandate seeking immediate medical attention for signs of a severe, life-threatening allergic reaction (anaphylaxis), such as wheezing, difficulty breathing, hives, or swelling of the face—these symptoms require urgent care regardless of the amount used. Since no specific antidote is known, the official management is symptomatic and supportive treatment, including continuous monitoring of vital signs, ECG, and specialized procedures like gastric lavage or administration of activated charcoal.

Therapeutic Uses of Clorhexil

Clorhexil is generally used to manage conditions where symptoms are related to inflammatory or irritative states caused by microbial presence, acting as an important antiseptic and germicide. This substance is utilized as part of symptomatic management to reduce bacteria on skin surfaces and wounds, and is applied across domains where additional symptomatic support is needed.

This product is used for managing symptom clusters related to inflammatory or irritative states in the mouth, such as gingival redness, swelling, and gum bleeding. It contributes to easing the overall symptom load in conditions like gingivitis, and also finds use in localized microbial contamination contexts, including minor cuts, scrapes, and post-procedural management following dental work.

“This application helps address the need for heightened germ control in various scenarios.”


Quick Fact: Relevant for Conditions Involving Inflammation Symptoms

Clorhexil supports the patient during symptomatic periods by being applied in addressing symptoms related to inflammatory or irritative states, particularly in cases of gum irritation and minor skin injury. It is considered relevant in clinical settings that involve complex management protocols, such as umbilical cord care in neonates or intensive care oral hygiene.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Clorhexil?

The population eligibility rules for Clorhexil (Chlorhexidine Gluconate) are defined strictly by regulatory labeling and focus on contraindications, age, and physiological status.


Contraindicated and Restricted Populations

Classification Population/Condition
Contraindicated Individuals with known hypersensitivity or allergy to Chlorhexidine Gluconate or any other component in the formulation.
Not Established/Recommended Pediatric patients under 18 years (clinical effectiveness and safety are not established for oral rinse).
Use Caution/Conditional Pregnant individuals (use is conditional and only if clearly needed, as adequate human studies are lacking).
Use Caution/Conditional Lactating/Nursing Mothers (caution is advised as it is not known if the drug is excreted in human milk).

Official Eligibility Rules and Limitations

The medicine is generally indicated for use in the adult population in the absence of absolute contraindications. Specific limitations exist for patients with certain medical conditions; for instance, the product's effect has not been determined in those with underlying periodontitis or acute necrotizing ulcerative gingivitis (ANUG). Furthermore, insufficient data were collected in trials to definitively assess differential responses in geriatric patients (aged 65 and over). Use in patients with hepatic or renal impairment does not typically require a dosage adjustment.

What should I know about interactions with other medicines?

The interaction profile for Clorhexil is uniquely structured by the drug's topical application and negligible systemic absorption, meaning it is characterized by local, pharmacodynamic interactions rather than systemic metabolic ones. Official regulatory documents consistently state the absence of systemic pharmacokinetic interactions with orally administered medicinal products, including those mediated by CYP enzymes or drug transporters.

The most significant documented interaction is a local chemical incompatibility with anionic agents. These agents are frequently included in conventional dentifrices and chemically inactivate the cationic active ingredient, Chlorhexidine Gluconate, which can reduce the product’s intended efficacy. To circumvent this inactivation, a timing separation rule is required: dentifrices containing anionic agents must be used before the Clorhexil rinse, with the mouth thoroughly rinsed with water between applications, or the applications must be entirely separated by time.

Additionally, co-administration with certain complex topical biologics, such as allogeneic cultured keratinocytes and dermal fibroblasts used in wound care, is restricted due to the potential for severe local interference or product inactivation. Furthermore, administration constraints in regulatory documents require avoiding the ingestion of food, drinks, or water immediately after use to ensure the sustained local activity of the product.

Mechanism of Action

The mechanism of action for Clorhexil (Chlorhexidine Gluconate) is defined by its core chemical properties, which initiate a sequence of events leading to the physiological consequence of microbial load reduction.

Direct Destruction of Microbial Cell Membranes

The primary mechanism begins with the electrostatic binding of the drug's cationic molecule to the negatively charged phospholipids in the microbial cell membrane. This binding physically compromises the membrane's integrity, leading to its rapid disruption and the leakage (efflux) of essential intracellular components like potassium ions. This action initiates a bacteriostatic effect, immediately interruption of microbial proliferation and preceding subsequent lethal events.

Inhibition of Cellular Energy and Protein Pathways

As the molecule penetrates the damaged cell membrane, it executes its bactericidal effect by causing the coagulation of cytoplasmic proteins and inhibiting vital membrane-bound enzymes, specifically those required for the ATP synthesis pathway. This irreversible destruction of internal metabolic machinery and protein structure stops the microbe's energy production and results in prompt cell death. This cascade is crucial for achieving the reduction of the microbial load.

⏱️ Mechanism Prolongation via Physical Binding (Substantivity)

A unique property of the drug is substantivity, where the molecule adheres chemically (chemisorption) to anionic binding sites on the oral mucosa and other tissues. This strong, residual binding creates a reservoir that slowly releases the active agent, thus sustaining a low, effective concentration at the site of application. This mechanism prolongs the functional presence of the active agent on local microbial populations.

Dosage and Administration Information

How Clorhexil Is Used: Administration Guidelines

Chlorhexidine Gluconate, marketed under trade names like Clorhexil, is administered through several approved routes depending on the formulation. The primary routes are oromucosal for the oral rinse, topical for solutions applied to the skin, and subgingival insertion for the extended-release periodontal chip.

Dosing and Frequency

The standard adult dosing for the 0.12% oral rinse is 15 mL of the undiluted solution per application. The typical application schedule is twice daily (B.I.D.), generally in the morning and evening, with each application requiring a 30-second rinse.

For the 2.5 mg periodontal chip, the regimen is one chip inserted per deep periodontal pocket, with a maximum of 8 chips per session. This treatment may be repeated once every three months if clinically necessary.

Administration Conditions and Constraints

The oral rinse should be used after meals to support its binding properties. Standard application involves the user expectorating the solution; the user must not rinse with water, brush, eat, or drink for at least 30 minutes following use. This substance is not intended for ingestion.

The safety and effectiveness of the oral rinse formulation have not been established in pediatric patients under 18 years in some regions. Conversely, specific 7.1% topical preparations are designated for daily neonatal umbilical care.

Recent Clinical Evidence

Research Evidence / Overview of studies for Clorhexil

Evidence for Adjunctive Use in Gingivitis Management

The body of research for the oral health applications of Clorhexil has been explored, primarily consisting of numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. These trials were designed to examine outcomes linked to inflammatory or irritative states in the mouth. Researchers focused on objectively measuring outcomes such as dental plaque accumulation and the presence of gum inflammation, using established index scores.

Studies report measurements indicating patterns of change in both plaque scores and gum inflammation that were observed in the groups studied. Follow-up durations were often limited to the short or intermediate term (up to six months), meaning that long-term outcomes and whether the measured changes persist are not fully established. Additionally, systematic reviews have noted high variability among the different study designs.

Evidence for Antiseptic Use in Critical Care Settings

Research has also studied the use of Clorhexil as a topical antiseptic in contexts where managing microbial presence is relevant. This evidence includes large Meta-analyses and multiple RCTs examining both the topical solution and the oral rinse used in critical care. Key outcomes that were studied included rates of specific hospital-acquired infections, such as those associated with the presence of central venous catheters, and the incidence of lung infections in patients on mechanical ventilation.

Findings describe patterns related to measured rates of Catheter Tip Colonization and Central Line-Associated Bloodstream Infections (CLABSI) in adult Intensive Care Unit (ICU) patients. However, data show patterns related to findings being mixed and inconsistent across different studies in the broader non-cardiac surgery ICU population. Furthermore, some large observational data sets reported patterns that suggest a potential association with increased mortality in general, non-ICU hospitalized patient populations.

Key Research Gaps and Uncertainties

Evidence quality varies across studies, particularly between the oral health RCTs and the limited clinical data available for minor wound cleansing. For infection prevention, the inconsistency of evidence in non-cardiac surgery settings suggests a research gap in fully characterizing the product's role across all ICU patient groups. The long-term effects on antimicrobial resistance patterns within healthcare settings are not fully established. Additionally, the findings describe group patterns, not personal outcomes, meaning that research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Antiseptic Efficacy and Cytotoxicity of Common Topical Antimicrobial Agents in a Human Keratinocyte-Fibroblast Co-Culture Model.
  2. Chlorhexidine Gluconate (Topical) Drug Information, Safety, and Limitations.

Frequently Asked Questions (FAQ)

Common questions about Clorhexil (FAQ)


Q: What are the established uses of Clorhexil outside of dental care?

The active ingredient in Clorhexil, Chlorhexidine Gluconate (CHG), is utilized beyond oral care. According to regulatory information, it is an ingredient in over-the-counter and prescription products used for cleaning and preparing the skin before medical procedures, such as surgery or injections. This application is intended to help reduce bacteria on the skin that could potentially cause infection.


Q: Are there methods described in official guidance to reduce Clorhexil staining?

Official documentation suggests that patients can take steps to minimize the staining of teeth and restorations. Methods described in official documentation include consistent daily oral hygiene, such as brushing and flossing, especially in areas that show signs of discoloration. Should staining occur, it can typically be removed by professional dental cleaning techniques.


Q: How long do taste changes last after stopping Clorhexil rinse?

Taste alteration, which is a commonly reported side effect, is generally described as temporary in regulatory documents. While the information indicates that taste changes may diminish with continued use, the exact duration of time required for resolution after the product is stopped is not universally specified. Postmarketing surveillance includes rare reports of permanent taste alteration.


Q: What is the usual time limit for using Clorhexil for gum conditions?

The oral rinse formulation is typically prescribed for short-term use. Regulatory labeling requires regular professional evaluation of the patient's condition, often at least every six months. The total duration of use is guided by the official prescribing information.


Q: What precautions are noted for using Clorhexil if a person has certain gum conditions?

Official labeling notes specific limitations for use in certain severe gum conditions. Regulatory documents state that the product’s effect on periodontitis has not been definitively determined. Furthermore, the product has not been tested in clinical trials among patients diagnosed with acute necrotizing ulcerative gingivitis (ANUG).


Q: Are there special considerations for elderly patients using Clorhexil?

Regulatory documents indicate that insufficient clinical data were collected during trials to definitively assess if patients 65 years of age and over respond differently to the drug compared to younger patients. However, in the absence of absolute contraindications, no specific dosage adjustment for age is typically required.


Q: Does Clorhexil interact with common over-the-counter pain medications?

Due to its primary action being localized and its systemic absorption being minimal, the oral rinse formulation is not known to have systemic interactions with most orally administered medicines, including common prescription or over-the-counter pain relievers.


Q: Can Clorhexil be safely used alongside other prescription topical skin products?

Specific clinical guidance suggests caution because the product’s effectiveness can be reduced by interaction with other ingredients. When additional topical products such as moisturizers or lotions are applied, using only those confirmed to be chemically compatible with Chlorhexidine Gluconate is advised to maintain efficacy.


Q: What types of dental work, like certain fillings, might react to Clorhexil?

The product can cause staining on oral surfaces, including dental restorations such as fillings. Official documents note that staining of some anterior (front) restorations may be permanent, and on rare occasions, the discoloration may be severe enough to require replacement of the material.


Q: How does Clorhexil compare to povidone-iodine as an antiseptic?

Clinical guidelines note that alcohol-based Chlorhexidine Gluconate solutions have been cited as having a generally faster action and more sustained antimicrobial activity in certain medical settings. Povidone-iodine is an accepted alternative in specific applications, such as on mucous membranes.


Q: Is it true that Clorhexil can increase dental calculus (tartar) buildup?

Yes, regulatory labeling indicates that an increase in supragingival calculus formation (tartar located above the gum line) was noted in clinical testing among oral rinse users compared with the control group.


Q: Can Clorhexil cause a dry mouth?

Dry mouth, clinically known as xerostomia, is one of the adverse reactions reported in postmarketing surveillance associated with the use of the oral rinse formulation. This is considered a localized side effect.


Q: Are there any restrictions on applying Clorhexil to areas with broken skin or deep cuts?

Specific protocols for the topical solution indicate that while it can be used on intact skin and superficial wounds, it is generally advised against using it on large or deep wounds, such as those that require packing.


Q: Does the inclusion of alcohol in some Clorhexil products affect its safety?

Topical solutions that contain alcohol are noted in regulatory warnings as being flammable. Official warnings state that due to the flammable nature of the alcohol component, the product is to be kept away from fire or flame. The solution is required to be completely dry before the use of ignition sources during medical procedures.


Q: Can Clorhexil products stain clothing or fabric?

Clinical care guidance notes that the product can cause staining on fabric. This occurs if the solution is transferred to cloth and then washed in a laundry cycle using bleach, leading to a chemical reaction that can result in a brown stain.


Q: Does Clorhexil have activity against viruses and fungi, or just bacteria?

The active ingredient is classified as a broad-spectrum biocide. Official documentation indicates it targets a range of organisms including both Gram-positive and Gram-negative bacteria, as well as fungi. Its primary function is based on disrupting the general microbial cell membrane.


Q: Is there a reported risk of bacteria developing resistance to Clorhexil over time?

Regulatory documents mention that one clinical study lasting six months did not demonstrate any significant changes in bacterial resistance or the overgrowth of potentially opportunistic organisms due to use.


Q: Is Clorhexil formulated to be free of gluten?

The 0.12% Chlorhexidine Gluconate oral rinse formulation is generally described as being gluten-free in its component information. This is based on required regulatory ingredient disclosures.


Q: What should a patient do if they accidentally swallow a small amount of the oral rinse?

Official overdose information states that if a small amount is swallowed, it might result in mild gastric distress, such as nausea. Regulatory overdose information describes that if signs consistent with alcohol intoxication develop, seeking medical attention is indicated.


Q: What are the non-personalized general expectations for the onset of Clorhexil's benefits?

Regulatory documents describe that the product's antimicrobial action begins during the application process. Its unique property, known as substantivity, allows it to bind to the site of application, which then helps to prolong the antiseptic action even after the rinse is completed.


Q: Is it necessary to dilute the Clorhexil product before using it?

The official directions for the 0.12% oral rinse formulation explicitly state that the product should be used undiluted. It is intended to be swished in the mouth for the prescribed amount of time and then expectorated.

How should Clorhexil be stored and disposed of?

How to Store and Dispose of Clorhexil (Chlorhexidine Gluconate)

The storage of Chlorhexidine Gluconate formulations is strictly governed by regulatory requirements to ensure product stability and safety. The product must be stored at controlled room temperature, typically 20 C to 25 C. It is mandatory to protect Clorhexil from light and excessive heat, and liquid solutions must not be frozen to prevent alteration of the preparation. The container should be kept tightly closed and in its original packaging.

A critical requirement is to keep the medicine out of the sight and reach of children.

Disposal must follow labeled instructions and local regulatory requirements. Products must not be thrown into wastewater or released into the environment. Unused solution from single-use containers must be discarded after the initial application.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clorhexil found in:

A-Z Index: